RETRACTED ARTICLE: Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery
暂无分享,去创建一个
Joachim Boldt | Michael Papsdorf | J. Boldt | M. Ducke | M. Papsdorf | B. Kumle | Bernhard Kumle | Michael Ducke | Ernst-Ludwig Zurmeyer | E. Zurmeyer
[1] W. Sibbald,et al. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. , 1994, Journal of applied physiology.
[2] R. Grounds,et al. Improving post-operative morbidity and mortality , 2002 .
[3] J. Engel,et al. Der Einfluss verschiedener Volumenersatzmittel auf die Funktion von neutrophilen Granulozyten in vitro , 2000, Der Anaesthesist.
[4] S. Banks,et al. EFFECTS OF RECOMBINANT HUMAN TUMOR NECROSIS FACTOR RECEPTOR (TNFR: Fc) ON THE CARDIOVASCULAR AND CYTOKINE RESPONSES OF NORMAL VOLUNTEERS FOLLOWING INTRAVENOUS ENDOTOXIN , 1994 .
[5] J. Carcillo,et al. Pro/con clinical debate: do colloids have advantages over crystalloids in paediatric sepsis? , 2002, Critical care.
[6] I. Chaudry,et al. Effects of trauma, duration of hypotension, and resuscitation regimen on cellular immunity after hemorrhagic shock , 1994, Critical care medicine.
[7] K. Huber,et al. Plasma concentrations of von Willebrand factor and intracellular adhesion molecule-1 for prediction of outcome after successful cardiopulmonary resuscitation , 2003, Critical care medicine.
[8] H. Baba,et al. Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia* , 2003, Critical care medicine.
[9] A. Webb,et al. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. , 1995, Archives of surgery.
[10] J. Boldt,et al. Does age affect liver function and the hepatic acute phase response after major abdominal surgery? , 2001, Intensive Care Medicine.
[11] A. Webb. Crystalloid or colloid for resuscitation. Are we any the wiser? , 1999, Critical care.
[12] J. Whicher,et al. Effects of resuscitation fluids on nonadaptive immune responses , 1997, Transfusion.
[13] P. Rhee,et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. , 1998 .
[14] S. Antonaci,et al. Neutrophil apoptotic cell death: does it contribute to the increased infectious risk in aging? , 2001, Microbios.
[15] J. K. Rose,et al. Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns (> or = 70% full-thickness). , 1997, Annals of surgery.
[16] C. Esmon. Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? , 2000, Blood.
[17] L. M. Cobb,et al. AGGRESSIVE FLUID RESUSCITATION FOLLOWING INTESTINAL ISCHEMIA‐REPERFUSION IN IMMATURE RATS PREVENTS METABOLIC DERANGEMENTS AND DOWN REGULATES INTERLEUKIN‐6 RELEASE , 1994, Shock.
[18] M. Wilson,et al. Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis. , 1996, The Journal of trauma.
[19] P. Rhee,et al. Lactated Ringer's solution resuscitation causes neutrophil activation after hemorrhagic shock. , 1998, The Journal of trauma.
[20] A. Webb,et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study , 2006, Intensive Care Medicine.
[21] M. Meisner,et al. Postoperative plasma concentrations of procalcitonin after different types of surgery , 1998, Critical Care.
[22] D. Heney,et al. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study , 1994, Critical care medicine.
[23] P. Sobotka,et al. Effects of the free radical scavenger DMTU and mannitol on the oxygen paradox in perfused rat hearts. , 1987, Journal of molecular and cellular cardiology.
[24] D. Scheinichen,et al. Effects of Hydroxyethyl Starch and Modified Fluid Gelatine on Phagocytic Activity of Human Neutrophils and Monocytes – Results of a Randomized, Prospective Clinical Study , 2000, Transfusion Medicine and Hemotherapy.
[25] M. James,et al. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. , 1998, British journal of anaesthesia.
[26] M. Singer,et al. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial , 1997, BMJ.
[27] J. Boldt,et al. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. , 2001, Anesthesia and analgesia.
[28] S. Zeerleder,et al. The endothelium in sepsis: Source of and a target for inflammation , 2001, Critical care medicine.
[29] L. Rink,et al. Altered cytokine production in the elderly , 1998, Mechanisms of Ageing and Development.
[30] T. Cook,et al. Hospital mortality after urgent and emergency laparotomy in patients aged 65 yr and over. Risk and prediction of risk using multiple logistic regression analysis. , 1998, British journal of anaesthesia.
[31] R. Hunter,et al. Reduction of myocardial infarct size by poloxamer 188 and mannitol in a canine model. , 1991, American heart journal.
[32] D. T. Eastlund,et al. Monocyte chemotaxis and chemotactic cytokine release after exposure to hydroxyethyl starch , 1992, Transfusion.